December 20, 2024

Will CAR T-Cell Therapy Be the Magic Bullet for My Multiple Myeloma?

“Intense pain on the right side of my lower rib cage, in 2020, sent me first to my chiropractor for relief and then to my primary care provider for tests. Because of the location of the pain, the chir...

The ASCO Post

December 18, 2024

Understanding the 2022 WHO Classification of Endocrine Tumors

From the parathyroid to adrenal glands and thyroid tumors, the latest WHO classification introduces essential updates to tumor nomenclature and diagnostic criteria.

Conexiant

December 18, 2024

Does Anger at Health Care Drive Change?

In-depth exploration of public anger towards the American health care system throughout history, potential for change, and Hollywood's portrayal of health insurance-related events.

KFF Health News

December 17, 2024

Pfizer: No Major Vaccine Shifts in 2025

Pfizer's CEO addressed the impact of potential vaccine policy changes and the nomination of a vaccine skeptic to run the Department of Health and Human Services, highlighting the company's commitment to advancing the right policies and overcoming challenges in the pharmaceutical market.

Reuters

December 16, 2024

Study Finds New Sexual Transmission Disease Risks

Review expands list of viruses persisting in human semen from 9 to 22.

Conexiant

December 16, 2024

New Guidelines Address Elder Surgery Care

Expanded preoperative evaluations can reduce postoperative delirium by 23% in older adults, but frailty doubles the risk—are your patients screened effectively?

Conexiant

December 12, 2024

Melanoma Recurrence Signs with ATLAS Guide

Study published in the Journal of the American Academy of Dermatology explores key symptoms and detection strategies for melanoma recurrence, providing potential improvements for surveillance protocols.

Conexiant

December 09, 2024

Study Highlights From MD Anderson Researchers

Here are some highlights of clinical trials presented at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting by researchers from The University of Texas MD Anderson Cancer Center. They ...

The ASCO Post

December 03, 2024

Roivant Ends Lung Drug After Trial

Roivant discontinues injectable drug namilumab for treating chronic active pulmonary sarcoidosis, citing failure to show treatment benefits in mid-stage trial.

Reuters